TH 0318
Alternative Names: Glucagon-like peptide-1 analogues - Theratechnologies; TH0318; ThGLP-1Latest Information Update: 01 Oct 2007
At a glance
- Originator ALZA Corporation; Theratechnologies
- Class
- Mechanism of Action Glucagon-like peptide 1 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 26 Sep 2007 GLP-1 portfolio of compounds licensed to OctoPlus worldwide for the treatment of diabetes and other potential indications
- 02 Oct 2006 TH 0318 is still available for out-licensing (http://www.theratech.com)
- 15 Mar 2006 TH 0318 is available for out-licensing (http://www.theratech.com)